Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Preferred Stock Liabilities: 2022

Historic Preferred Stock Liabilities for Orchestra BioMed Holdings (OBIO) over the last 1 years, with Dec 2022 value amounting to $67.7 million.

  • Orchestra BioMed Holdings' Preferred Stock Liabilities was N/A to $67.7 million in Q4 2022 from the same period last year, while for Dec 2022 it was $67.7 million, marking a year-over-year change of. This contributed to the annual value of $67.7 million for FY2022, which is N/A change from last year.
  • Orchestra BioMed Holdings' Preferred Stock Liabilities amounted to $67.7 million in Q4 2022, which was down 0.00% from $67.7 million recorded in Q3 2022.
  • In the past 5 years, Orchestra BioMed Holdings' Preferred Stock Liabilities registered a high of $160.1 million during Q2 2022, and its lowest value of $67.7 million during Q3 2022.
  • Its 1-year average for Preferred Stock Liabilities is $113.9 million, with a median of $113.8 million in 2022.